Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nephros | NEPH | Nov 15, 2024 | 1.56 | -1.27 |
NerdWallet A | NRDS | Nov 15, 2024 | 13.88 | -4.67 |
Nerdy A | NRDY | Nov 15, 2024 | 0.96 | +13.73 |
Net Lease Office Properties When Issued | NLOP | Nov 15, 2024 | 30.94 | -0.58 |
Net Power A | NPWR | Nov 15, 2024 | 12.67 | -3.28 |
NetApp | NTAP | Nov 15, 2024 | 117.21 | -0.73 |
Netcapital | NCPL | Nov 15, 2024 | 1.73 | -1.70 |
NetEase ADR | NTES | Nov 15, 2024 | 85.49 | +1.51 |
Netflix | NFLX | Nov 15, 2024 | 823.96 | -1.59 |
NETGEAR | NTGR | Nov 15, 2024 | 24.15 | 0.00 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 15, 2024 | 44.74 | -0.97 |
NetScout Systems | NTCT | Nov 15, 2024 | 21.86 | -2.50 |
NETSOL Technologies | NTWK | Nov 15, 2024 | 2.69 | -6.27 |
Netstreit | NTST | Nov 15, 2024 | 15.45 | -0.06 |
Network-1 Technologies | NTIP | Nov 15, 2024 | 1.35 | 0.00 |
Neuberger Berman | NML | Nov 15, 2024 | 8.92 | -0.56 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 15, 2024 | 7.71 | -2.77 |
Neuberger Berman Municipal Fund | NBH | Nov 15, 2024 | 10.68 | -0.09 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 15, 2024 | 12.89 | -2.50 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 15, 2024 | 3.73 | -2.10 |
NeueHealth | NEUE | Nov 15, 2024 | 5.00 | -1.38 |
Neumora Therapeutics | NMRA | Nov 15, 2024 | 10.84 | -7.27 |
Neuraxis | NRXS | Nov 15, 2024 | 3.15 | -3.67 |
Neurobo Pharmaceuticals | NRBO | Nov 15, 2024 | 2.22 | -7.11 |
Neurocrine Biosciences | NBIX | Nov 15, 2024 | 117.44 | -4.42 |
Neurogene | NGNE | Nov 15, 2024 | 34.52 | -11.95 |
NeuroMetrix | NURO | Nov 15, 2024 | 3.93 | +3.69 |
Neuronetics | STIM | Nov 15, 2024 | 0.71 | -10.13 |
NeuroOne | NMTC | Nov 15, 2024 | 0.71 | -8.96 |
Neuropace | NPCE | Nov 15, 2024 | 8.98 | -7.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.